Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 41.37B | 41.23B | 51.03B | 38.96B | 35.44B |
Gross Profit | 6.21B | 4.73B | 9.45B | 6.73B | 6.77B |
EBITDA | 2.01B | 502.00M | 4.81B | 2.44B | 2.51B |
Net Income | 350.00M | -630.00M | 2.17B | 1.02B | 829.00M |
Balance Sheet | |||||
Total Assets | 50.09B | 48.65B | 49.39B | 43.07B | 40.53B |
Cash, Cash Equivalents and Short-Term Investments | 2.10B | 2.33B | 1.90B | 2.00B | 2.81B |
Total Debt | 14.85B | 12.40B | 10.12B | 7.21B | 7.31B |
Total Liabilities | 26.23B | 25.09B | 24.56B | 20.05B | 18.23B |
Stockholders Equity | 23.82B | 23.50B | 24.78B | 22.97B | 22.25B |
Cash Flow | |||||
Free Cash Flow | -1.76B | -944.00M | -2.44B | -896.00M | 630.00M |
Operating Cash Flow | 152.00M | 1.52B | -1.21B | 341.00M | 2.65B |
Investing Cash Flow | -2.48B | -2.21B | -1.24B | -529.00M | -1.94B |
Financing Cash Flow | 2.11B | 1.12B | 2.35B | -624.00M | -1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥39.40B | 9.91 | 2.34% | 4.52% | 9.37% | ||
76 Outperform | ¥26.55B | 10.88 | 3.48% | 10.55% | 31.08% | ||
75 Outperform | ¥18.76B | 14.62 | 1.93% | 9.14% | 6.18% | ||
69 Neutral | ¥105.84B | 9.66 | 4.02% | 10.07% | -38.38% | ||
68 Neutral | ¥9.03B | 25.85 | 1.97% | 0.33% | ― | ||
58 Neutral | HK$18.08B | 5.64 | -7.29% | 3.84% | -4.25% | -46.87% |